Expoint - all jobs in one place

The point where experts and best companies meet

Limitless High-tech career opportunities - Expoint

GE HealthCare Oncology Leader Theranostics Strategy & Growth - USCAN 
Mexico, Mexico City 
694814877

Yesterday
Job Description
  • Own the regional commercial strategyto drive market share, profitability and revenue growth metrics within the USCAN region.

  • Promote the entire GEHC theranostics value chain from isotope, to molecule, to digital, to outcome journey and ensure a single product marketing story to the clinical and pharma customer.

  • Be the regional point of contact for theranostics and the go to leader for the strategic business units (SBU), regional business units (RBU), and care area oncology teams.

  • Own key customer relationships and academic KOL partnerships – in line with SBU, RBU and CA priorities.

Responsibilities
  • Work across SBUs, RBUs, CAs and across functions to:

    • Develop the overall theranostics value proposition and the selection and positioning of key GEHC technologies within the theranostics offering.

    • Lead the coordination, execution and best practice sharing across the “One GEHC Theranostics” team, providing a regular operating mechanism for communication across RBU segments.

    • Define the market access plan, customer outcomes benefits (clinical and health economic), reimbursement and incentive strategy and cross-regional best practice.

    • Use market and internal data, tools, statistics and trends to build the regional product and overall solution opportunity funnel

    • Build existing and break into new sites with our theranostics offering

  • Forecast, execute, manage and grow orders & sales

    • Establish partnerships and drive clinical and health economic outcomes for our partners and customers

    • Track, analyse and interpret sales and partnership data to drive further improvements.

    • Development of new inorganic business opportunities to complement and grow the overall theranostics franchise.

  • Be accountable to achieve the agreed quarterly and yearly operating plan targets

  • Be accountable for timely and accurate forecasting of pipeline and sales per the normal reporting cycles within USCAN.

  • Provide input to the formulation of the yearly business planning cycles for the theranostics franchise e.g. Long Term Strategy (LTS).

  • Spend 90% of the time in the field visiting customers, executing partnerships & sales growth

  • Continuously develop deep clinical and technical knowledge including awareness of current and future trends in theranostics and molecular imaging technology.

  • Understand and analyze market dynamics and competition to develop business opportunities for the franchise.

  • Provide ongoing feedback to management, region and marketing.

Basic Qualifications:
  • Education to Bachelor degree leveland desirably a postgraduate in Business Management and or Marketing (e.g. MBA).

  • A minimum of 3-5 years of experience in Commercial/Sales/Strategy functions in healthcare provision / medical device / pharmaceutical industry and/or within a Health System within Theranostics.

  • Experience in finance / consulting / business leadership / oncology product / clinical marketing will be an added advantage.

  • Exemplary people management, leadership skills, as well as sales coaching and team building skills.

  • Advanced negotiation, problem solving and influencing skills.

  • High level presentation and interpersonal skills; able to communicate and present ideas to customers in a way that produces understanding and impact that builds effective strategic relationships.

  • Ability to energize, develop, and build rapport, collaboration and influence at all levels within an organization.

Desired Qualifications
  • Can apply critical thinking skills and disciplined approaches to help leaders and leadership teams resolve issues and define solutions

  • Knows how to effectively manage risk and uncertainty for self and team. Makes decisions with confidence when problems or solutions are not 100% defined

Application Deadline: December 30, 2024